BIO Announces Initial Companies Selected to Present at the Inaugural BIO India International Partnering Conference

Conference will be held September 21-22 in Hyderabad, India

WASHINGTON--(BUSINESS WIRE)-- The Biotechnology Industry Organization (BIO) today announced initial companies selected through a competitive screening process to present at the inaugural BIO India International Partnering Conference.

“Our distinguished Advisory Committee recommended these companies because they represent significant investment opportunities based on their promising innovative therapeutic advances,” said Alan Eisenberg, executive vice president, Emerging Companies & Business Development at BIO. “These firms are a snapshot representing the growth of R&D as well as pure discovery work in India. We look forward to announcing additional companies shortly.”

The following companies will present at Bio India:

Aurigene Discovery Technologies
Cellworks
Connexios Life Sciences
CureVac GmbH
Incozen Therapeutics Pvt, Ltd.
Indus Biotech Pvt, Ltd.
Jubilant BioSys Ltd
KemWell Pharma
Mitra Biotech Pvt, Ltd.
Novalead Pharma Pvt, Ltd.
Novo Nordisk A/S
Spectrum Pharmaceuticals

A total of 30 presenting companies will be selected and posted on the conference website on a rolling basis. To view the latest list of presenting companies, please visit www.bio.org/bioindia.

Dr. Rashmi Barbhaiya
CEO and Managing Director, Advinus Therapeutics Pvt, Ltd.
Dr. Simon Best
CEO, Aquapharm, Ltd. and Chairman, Edinburgh BioQuarter
Dr. Vijay Chandru
Chairman and CEO, Strand LS & President, ABLE
Mr. Jim Geraghty
Senior Vice President, Genzyme, Inc.
Mr. William Greene
Managing Director, MPM Capital
Mr. Joel Marcus
CEO, Alexandria Real Estate Equities, Inc.
Mr. Sri Mosur
President and CEO, Jubilant Discovery Services, Inc. and Jubilant Biosys, Ltd.
Mr. Utkarsh Palnitkar
Executive Director, Centrum Capital, Ltd.
Dr. Jasmin Patel
Managing Director, FIL Capital Advisors (India) Pvt Ltd.
Dr. Swati Piramal
Vice Chairperson, Piramal Lifesciences, Ltd.
Dr. Sunny Sharma
Managing Director, Asia, OrbiMed Advisors India Private, Ltd.
Mrs. Kiran Mazumdar Shaw
Chairman & Managing Director, Biocon, Ltd.
Mr. Sujay J. Shetty
Leader, Pharma Life Sciences Advisory
PricewaterhouseCoopers (PwC)
Mr. K.V. Subramaniam
President & CEO, Reliance Life Sciences
Dr. M. Vidyasagar
Cecil and Ida Green (II) Chair Professor, Erik Jonsson School of Engineering & Computer Science, The University of Texas at Dallas

BIO India will bring together biotechnology and pharmaceutical companies from North America, Europe and Asia to meet and explore business opportunities with India’s emerging biotech sector.

BIO brings to India more than ten years of experience and expertise in biotech and pharmaceutical partnering. BIO is renowned for its successful partnering meetings in the U.S., Japan and Germany, including the biotech world’s largest partnering event, the Business Forum, at the BIO International Convention. ABLE, BIO’s partner in India, brings to the meeting extensive local expertise and its comprehensive network of Indian and Asian biotech and pharmaceutical companies.

Private one-on-one meetings between investors, large biotech and pharmaceutical companies and emerging Indian biotech companies will be arranged through BIO’s new state-of-the-art software.

To learn more about BIO India, including registration and program information, please visit www.bio.org/bioindia. Registration is complimentary for qualified investors and credentialed members of the media.

About BIO

BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.

About ABLE

ABLE is a national forum that represents the India biotechnology sector. ABLE was launched by leaders in the biotech industry and has over 200 members from various verticals in the biotech sector. ABLE’s objectives are to promote entrepreneurship, investments and partnerships in the biotech sector, working with the government in their biotech initiatives and disseminating information on the biotech sector.

Upcoming BIO Events

BIO India International Partnering Conference
September 21 - 22, 2010
Hyderabad, India

BIO’s Livestock Biotechnology Summit
September 28-30, 2010,
Sioux Falls, SD

9th Annual BIO Investor Forum
October 5-6, 2010
San Francisco, CA

BIO Intellectual Property Counsels Committee Fall Conference and Committee Meeting
October 18-20, 2010
Boston, MA

Advanced Business Development Course
November 12-14, 2010
Munich, Germany

BIO-Europe International Partnering Conference
November 15-17, 2010
Munich, Germany

Pacific Rim Summit on Industrial Biotechnology and Bioenergy
December 11-14, 2010
Honolulu, HI



CONTACT:

Biotechnology Industry Organization (BIO)
Erin Reese, 202-962-9235
www.bio.org

KEYWORDS:   United States  Asia Pacific  North America  District of Columbia  India

INDUSTRY KEYWORDS:   Technology  Other Technology  Health  Biotechnology  Pharmaceutical

MEDIA:

Logo
 Logo

Suggested Articles

Xcovery's ALK inhibitor shrank tumors in 75% of lung cancer patients, compared to 67% for Pfizer's Xalkori, the first FDA-approved drug of that class.

The FDA accepted the regulatory filing for Biogen's once-failed Alzheimer's drug, aducanumab, with plans to decide its fate by March 7, 2021.

Alexion named a chief diversity officer, while COVID-19 vaccine player has two new members of its C-suite.